Cargando…
CCR5Δ32 mutations do not determine COVID-19 disease course
OBJECTIVES: To determine the impact of the 32 bp deletion (CCR5Δ32) in the coding region of the C-C chemokine receptor 5 (CCR5) on the risk of contracting SARS-CoV-2 and severe COVID-19. METHODS: Cross-sectional study among stem cell donors registered with DKMS in Germany. Genetic information was li...
Autores principales: | Bernas, Stefanie N., Baldauf, Henning, Wendler, Sarah, Heidenreich, Falk, Lange, Vinzenz, Hofmann, Jan A., Sauter, Jürgen, Schmidt, Alexander H., Schetelig, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923852/ https://www.ncbi.nlm.nih.gov/pubmed/33667698 http://dx.doi.org/10.1016/j.ijid.2021.02.108 |
Ejemplares similares
-
Individual HLA-A, -B, -C, and -DRB1 Genotypes Are No Major Factors Which Determine COVID-19 Severity
por: Schetelig, Johannes, et al.
Publicado: (2021) -
Post‐COVID‐19 condition in the German working population: A cross‐sectional study of 200,000 registered stem cell donors
por: Bernas, Stefanie N., et al.
Publicado: (2022) -
The Case for Selection at CCR5-Δ32
por: Sabeti, Pardis C, et al.
Publicado: (2005) -
Association between the CCR5Δ32 polymorphism and preeclampsia
por: Paula Telini, Bianca de, et al.
Publicado: (2014) -
CCR5-Δ32 is deleterious in the homozygous state in humans
por: Wei, Xinzhu, et al.
Publicado: (2019)